Evidence map›Paper›PMID 42402984›Full record

Trial reportHuman brain mapping2026

GABAergic Modulation of Brain Function During Prosaccade and Antisaccade Eye Movements: Evidence From Ultra-High-Field fMRI.

Paulina Quint, Pia-Magdalena Schmidt, Sarah Mackert, Behrem Aslan, Matthias Guth, Leon von der Emde, Raphael Lechtenboehmer, Kaja Faßbender, Philine M Baumert, Birgit Stoffel-Wagner and 4 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paulina QuintDepartment of Psychology, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0006-0141-6018
Pia-Magdalena SchmidtDepartment of Psychology, University of Bonn, Bonn, Germany.
Sarah MackertDepartment of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.
Behrem AslanDepartment of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.
Matthias GuthDepartment of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.
Leon von der EmdeDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Raphael LechtenboehmerDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Kaja FaßbenderDepartment of Psychology, University of Bonn, Bonn, Germany.
Philine M BaumertDepartment of Psychology, University of Bonn, Bonn, Germany.
Birgit Stoffel-WagnerInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Ramona Dolscheid-PommerichInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Rüdiger StirnbergGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Tony StöckerGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID https://orcid.org/0000-0002-8946-9141
Ulrich EttingerDepartment of Psychology, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-0160-0281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzodiazepines act as positive allosteric modulators of the GABA

Indexed as

BrainGABA Modulatorsgamma-Aminobutyric AcidLorazepamSaccadesAdultBrain MappingDouble-Blind MethodFemaleHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleOxygenReaction TimeReceptors, GABA-AGABA Modulatorsgamma-Aminobutyric AcidLorazepamOxygenReceptors, GABA-Abenzodiazepineseye‐trackingfMRIGABAA receptorinhibitory controlsaccades

Identifiers

PMID42402984
PMCPMC13334141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.